메뉴 건너뛰기




Volumn 25, Issue 5, 2007, Pages 709-715

The effect of cyclosporine A on bone density in female rheumatoid arthritis patients: Results from a multicenter, cross-sectional study

(41)  Mazzantini, Maurizio a   Di Munno, Ombretta a   Sinigaglia, Luigi b   Bianchi, Gerolamo c   Rossini, Maurizio d   Mela, Quirico e   Del Puente, Antonio f   Frediani, Bruno g   Cantatore, Francesco h,n   Adami, Silvano d   Bartolone, S i   Girasole, G c   Rovetta, G j   Broggini, M k   Citi, M l   Canesi, B m   Meneghin, M m   Ciocci, A o   Consoli, G p   Di Matteo, G p   more..


Author keywords

Bone loss; Cyclosporine A; Osteoporosis; Rheumatoid arthritis

Indexed keywords

ANABOLIC AGENT; BISPHOSPHONIC ACID DERIVATIVE; CALCITONIN; CALCIUM; CYCLOSPORIN A; ESTROGEN; FLUORIDE; STEROID; THIAZIDE DIURETIC AGENT; VITAMIN D;

EID: 37349132303     PISSN: 0392856X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article
Times cited : (13)

References (29)
  • 1
    • 0025265635 scopus 로고
    • Low-dose cyclosporin versus placebo in patients with rheumatoid arthritis
    • TUGWELL P, BOMBARDIER C, GENT M et al.: Low-dose cyclosporin versus placebo in patients with rheumatoid arthritis. Lancet 1990; 335: 1051-5.
    • (1990) Lancet , vol.335 , pp. 1051-1055
    • TUGWELL, P.1    BOMBARDIER, C.2    GENT, M.3
  • 2
    • 23444449002 scopus 로고
    • A randomized, double-blind, 24-week controlled study of low-dose cyclosporine versus chloroquine for early rheumatoid arthritis
    • LANDEWE RB, GOEI THE HS, VAN RIJTHOVEN AW, BREEDVELD FC, DIJKMANS BA: A randomized, double-blind, 24-week controlled study of low-dose cyclosporine versus chloroquine for early rheumatoid arthritis. Arthritis Rheum 1994; 37: 637-43.
    • (1994) Arthritis Rheum , vol.37 , pp. 637-643
    • LANDEWE, R.B.1    GOEI, T.H.2
  • 3
    • 0027987025 scopus 로고
    • Radiologic evidence of disease modification in rheumatoid arthritis patients treated with cyclosporine. Results of a 48-week multicenter study comparing low-dose cyclosporine with placebo. Norwegian Arthritis Study Group
    • FØRRE O: Radiologic evidence of disease modification in rheumatoid arthritis patients treated with cyclosporine. Results of a 48-week multicenter study comparing low-dose cyclosporine with placebo. Norwegian Arthritis Study Group. Arthritis Rheum 1994; 37: 1506-12.
    • (1994) Arthritis Rheum , vol.37 , pp. 1506-1512
    • FØRRE, O.1
  • 4
    • 8944256867 scopus 로고    scopus 로고
    • Slow progression of joint damage in early rheumatoid arthritis treated with cyclosporin A
    • PASERO G, PRIOLO F, MARUBINI E et al.: Slow progression of joint damage in early rheumatoid arthritis treated with cyclosporin A. Arthritis Rheum 1996; 39: 1006-15.
    • (1996) Arthritis Rheum , vol.39 , pp. 1006-1015
    • PASERO, G.1    PRIOLO, F.2    MARUBINI, E.3
  • 5
    • 0030067972 scopus 로고    scopus 로고
    • Post-transplantatiTn bone disease: The role of immunosuppressive agents and the skeleton
    • EPSTEIN S: Post-transplantatiTn bone disease: the role of immunosuppressive agents and the skeleton. J Bone Miner Res 1996; 11: 1-7.
    • (1996) J Bone Miner Res , vol.11 , pp. 1-7
    • EPSTEIN, S.1
  • 6
    • 0028348583 scopus 로고
    • The deleterious effects of long-term cyclosporine A, cyclosporine G and FK506 on bone mineral metabolism in vivo
    • CVETKOVIC M, MANN GN, ROMERO DF et al.: The deleterious effects of long-term cyclosporine A, cyclosporine G and FK506 on bone mineral metabolism in vivo. Transplantation 1994; 57: 1231-7.
    • (1994) Transplantation , vol.57 , pp. 1231-1237
    • CVETKOVIC, M.1    MANN, G.N.2    ROMERO, D.F.3
  • 7
    • 0023708625 scopus 로고
    • Cyclosporine A in vivo produces severe osteopenia in the rat: Effect of dose and duration of administration
    • MVSOWITZ C, EPSTEIN S, FALLON M et al.: Cyclosporine A in vivo produces severe osteopenia in the rat: Effect of dose and duration of administration. Endocrinology 1988; 123: 2571-7.
    • (1988) Endocrinology , vol.123 , pp. 2571-2577
    • MVSOWITZ, C.1    EPSTEIN, S.2    FALLON, M.3
  • 8
    • 0027954919 scopus 로고
    • Influence of age on cyclosporine A-induced alterations in bone mineral metabolism in the rat in vivo
    • KATZ I, LI MEI, JOFFE I et al.: Influence of age on cyclosporine A-induced alterations in bone mineral metabolism in the rat in vivo. J Bone Miner Res 1994; 9: 59-67.
    • (1994) J Bone Miner Res , vol.9 , pp. 59-67
    • KATZ, I.1    LI, M.E.I.2    JOFFE, I.3
  • 9
    • 0032971518 scopus 로고    scopus 로고
    • Mechanisms of bone loss following allogeneic and autologous hemopoietic stem cell transplantation
    • EBELING PR, THOMAS DM, ERBAS B, HOPPER JL, SZER J, GRIGG AP: Mechanisms of bone loss following allogeneic and autologous hemopoietic stem cell transplantation. J Bone Miner Res 1999; 14: 342-50.
    • (1999) J Bone Miner Res , vol.14 , pp. 342-350
    • EBELING, P.R.1    THOMAS, D.M.2    ERBAS, B.3    HOPPER, J.L.4    SZER, J.5    GRIGG, A.P.6
  • 12
    • 0029046374 scopus 로고
    • Prevention of cancellous bone loss but persistence of renal bone disease despite normal 1, 25 vitamin D levels two years after kidney transplantation
    • BRINER VA, THIEL G, MONIER-FAUGERE MC et al.: Prevention of cancellous bone loss but persistence of renal bone disease despite normal 1, 25 vitamin D levels two years after kidney transplantation. Transplantation 1995; 59: 1393-400.
    • (1995) Transplantation , vol.59 , pp. 1393-1400
    • BRINER, V.A.1    THIEL, G.2    MONIER-FAUGERE, M.C.3
  • 13
    • 0028923370 scopus 로고
    • Long-term bone loss after renal transplCntation: Comparison of immunosuppressive regimens
    • MCINTYRE HD, MENZIES B, RIGBY R, PERRY KEENE DA, HAWLEY CM, HARDIE IR: Long-term bone loss after renal transplCntation: comparison of immunosuppressive regimens. Clin Transpl 1995; 9: 20-4.
    • (1995) Clin Transpl , vol.9 , pp. 20-24
    • MCINTYRE, H.D.1    MENZIES, B.2    RIGBY, R.3
  • 14
    • 0031016377 scopus 로고    scopus 로고
    • Effects of three immunosuppressive regimens on vertebral bone density in renal transplant recipients - a prospective study
    • AROLDI A, TARANTINO A, MONTAGNINO G, CESANA B, COCUCCI C, PONTICELLI C: Effects of three immunosuppressive regimens on vertebral bone density in renal transplant recipients - a prospective study. Transplantation 1997; 63: 380-6.
    • (1997) Transplantation , vol.63 , pp. 380-386
    • AROLDI, A.1    TARANTINO, A.2    MONTAGNINO, G.3    CESANA, B.4    COCUCCI, C.5    PONTICELLI, C.6
  • 15
    • 0031965305 scopus 로고    scopus 로고
    • Long-term bone densitometry post-renal transplantation in patients treated with either cyclosporine or prednisolone
    • PARRY RG, JACKSON J, STEVENS JM, HIGGINS B, ALTMANN P: Long-term bone densitometry post-renal transplantation in patients treated with either cyclosporine or prednisolone. Nephrol Dial Transplant 1998; 13: 531-2.
    • (1998) Nephrol Dial Transplant , vol.13 , pp. 531-532
    • PARRY, R.G.1    JACKSON, J.2    STEVENS, J.M.3    HIGGINS, B.4    ALTMANN, P.5
  • 16
    • 0032917787 scopus 로고    scopus 로고
    • Bone loss in long-term renal transplantation: Histopathology and densitometry analysis
    • CUETO-MANZANO AM, KONEL S, HUTCHISON AJ et al.: Bone loss in long-term renal transplantation: Histopathology and densitometry analysis. Kidney Int 1999; 55: 2021-9.
    • (1999) Kidney Int , vol.55 , pp. 2021-2029
    • CUETO-MANZANO, A.M.1    KONEL, S.2    HUTCHISON, A.J.3
  • 17
    • 0033797498 scopus 로고    scopus 로고
    • Cyclosporine bone remodelling effect prevents steroid osteopenia after kidney transplantation
    • WESTEEL FP, MAZOUZ H, EZAITOUNI F et al.: Cyclosporine bone remodelling effect prevents steroid osteopenia after kidney transplantation. Kidney Int 2000; 58: 1788-96.
    • (2000) Kidney Int , vol.58 , pp. 1788-1796
    • WESTEEL, F.P.1    MAZOUZ, H.2    EZAITOUNI, F.3
  • 18
    • 0029742877 scopus 로고    scopus 로고
    • Increase of bone mineral density and anabolic variables in patients with rheumatoid arthritis resistant to methotrexate after cyclosporin A therapy
    • FERRACCIOLI G, CASATTA L, BARTOLI E: Increase of bone mineral density and anabolic variables in patients with rheumatoid arthritis resistant to methotrexate after cyclosporin A therapy. J Rheumatol 1996; 23: 1539-42.
    • (1996) J Rheumatol , vol.23 , pp. 1539-1542
    • FERRACCIOLI, G.1    CASATTA, L.2    BARTOLI, E.3
  • 19
    • 0033748422 scopus 로고    scopus 로고
    • A multicenter cross sectional study on bone mineral density in rheumatoid arthritis
    • SINIGAGLIA L, NERVEITI A, MELA Q et al.: A multicenter cross sectional study on bone mineral density in rheumatoid arthritis. J Rheumatol 2000; 27: 2582-9.
    • (2000) J Rheumatol , vol.27 , pp. 2582-2589
    • SINIGAGLIA, L.1    NERVEITI, A.2    MELA, Q.3
  • 20
    • 3042770431 scopus 로고    scopus 로고
    • Effect of low dose methotrexate on bone density in women with rheumatoid arthritis: Results from a multicenter cross-sectional study
    • DI MUNNO O, MAZZANTINI M, SINIGAGLIA L et al.: Effect of low dose methotrexate on bone density in women with rheumatoid arthritis: Results from a multicenter cross-sectional study. J Rheumatol 2004; 31: 1305-9.
    • (2004) J Rheumatol , vol.31 , pp. 1305-1309
    • DI MUNNO, O.1    MAZZANTINI, M.2    SINIGAGLIA, L.3
  • 21
    • 0034047128 scopus 로고    scopus 로고
    • Vertebral bone mineral density changes in female rheumatoid arthritis patients treated with low-dose methotrexate
    • MAZZANTINI M, INCERTI-VECCHI L, DI MUNNO O, PASERO O: Vertebral bone mineral density changes in female rheumatoid arthritis patients treated with low-dose methotrexate. Clin Exp Rheumatol 2000; 18: 327-31.
    • (2000) Clin Exp Rheumatol , vol.18 , pp. 327-331
    • MAZZANTINI, M.1    INCERTI-VECCHI, L.2    DI MUNNO, O.3    PASERO, O.4
  • 22
    • 72649098710 scopus 로고
    • Therapeutic criteria in rheumatoid arthritis
    • STEINBROCKER O, TRAEGER CH, BATTERMAN RC: Therapeutic criteria in rheumatoid arthritis. JAMA 1949; 140: 659-62.
    • (1949) JAMA , vol.140 , pp. 659-662
    • STEINBROCKER, O.1    TRAEGER, C.H.2    BATTERMAN, R.C.3
  • 23
    • 37349074562 scopus 로고    scopus 로고
    • WHO STUDY GROUP: Osteoporosis. In: Assessment of Fracture Risk and its Application to Screening for Postmenopausal Osteoporosis. Technical Report Series 843. Geneva, WHO, 1994: 2-25.
    • WHO STUDY GROUP: Osteoporosis. In: Assessment of Fracture Risk and its Application to Screening for Postmenopausal Osteoporosis. Technical Report Series 843. Geneva, WHO, 1994: 2-25.
  • 24
    • 0019407824 scopus 로고
    • Preliminary criteria for clinical remission in rheumatoid arthritis
    • PINALS RS, MASI AT, LARSEN RA: Preliminary criteria for clinical remission in rheumatoid arthritis. Arthritis Rheum 1981; 24: 1308-15.
    • (1981) Arthritis Rheum , vol.24 , pp. 1308-1315
    • PINALS, R.S.1    MASI, A.T.2    LARSEN, R.A.3
  • 25
    • 18644368299 scopus 로고    scopus 로고
    • Disease-modifying anti-rheumatic drugs and bone mass in rheumatoid arthritis
    • DI MUNNO O, DELLE SEDIE, ROSSINI M, ADAMI S: Disease-modifying anti-rheumatic drugs and bone mass in rheumatoid arthritis. Clin Exp Rheumatol 2005; 23: 137-44.
    • (2005) Clin Exp Rheumatol , vol.23 , pp. 137-144
    • DI MUNNO, O.1    DELLE, S.E.D.I.E.2    ROSSINI, M.3    ADAMI, S.4
  • 26
    • 17844410337 scopus 로고    scopus 로고
    • Clinical review: Osteoporosis after solid organ transplantation
    • MAALOUF NM,OSHANE E: Clinical review: osteoporosis after solid organ transplantation. J Clin Endrocrinol Metab 2005; 90: 2456-65.
    • (2005) J Clin Endrocrinol Metab , vol.90 , pp. 2456-2465
    • MAALOUF, N.M.1    OSHANE, E.2
  • 27
    • 16244372694 scopus 로고    scopus 로고
    • Post-transplantation bone disease
    • CUNNINGHAM J: Post-transplantation bone disease. Transplantation 2005: 79: 629-34.
    • (2005) Transplantation , vol.79 , pp. 629-634
    • CUNNINGHAM, J.1
  • 28
    • 0034817070 scopus 로고    scopus 로고
    • Effects of immunosuppressants on the receptor activator of NF-kappaB ligand and osteoprotegerin production by human osteoblastic and coronary artery smooth cells
    • HOFBAUER LC, SHUI C, RIGGS BL et al.: Effects of immunosuppressants on the receptor activator of NF-kappaB ligand and osteoprotegerin production by human osteoblastic and coronary artery smooth cells. Biochem Biophys Res Commun 2001: 280: 334-9.
    • (2001) Biochem Biophys Res Commun , vol.280 , pp. 334-339
    • HOFBAUER, L.C.1    SHUI, C.2    RIGGS, B.L.3
  • 29
    • 26944454882 scopus 로고    scopus 로고
    • Bone metabolism in renal transplant patients treated with cyclosporine or sirolimus
    • and the SIROLIMUS EUROPEAN RENAL TRANSPLANT STUDY GROUP
    • CAMPISTOL JM, HOLT DW, EPSTEIN S, GIOUD-PAQUET M, RUTAULT K, BURKE JT and the SIROLIMUS EUROPEAN RENAL TRANSPLANT STUDY GROUP: Bone metabolism in renal transplant patients treated with cyclosporine or sirolimus. Transpl Int 2005; 18: 1028-35.
    • (2005) Transpl Int , vol.18 , pp. 1028-1035
    • CAMPISTOL, J.M.1    HOLT, D.W.2    EPSTEIN, S.3    GIOUD-PAQUET, M.4    RUTAULT, K.5    BURKE, J.T.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.